Washington Trust Advisors’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Washington Trust Advisors’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-999	Closed	-$20	–	789
2023 Q1	$20	Hold	999	–	–	﹤0.01%	776
2022 Q4	$149	Hold	999	–	–	﹤0.01%	777
2022 Q3	$0	Hold	999	–	–	﹤0.01%	947
2022 Q2	$0	Hold	999	–	–	﹤0.01%	1005
2022 Q1	$1K	Hold	999	–	–	﹤0.01%	992
2021 Q4	$1K	Buy	+999	New	+$1.01K	﹤0.01%	996

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Washington Trust Advisors's PEARW Position: Q2 2023 in Review

Washington Trust Advisors sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 999 shares — an estimated $20 sold.

Washington Trust Advisors first reported a position in PEARW in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q1 2022. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Washington Trust Advisors reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Washington Trust Advisors sold 999 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $20.
Washington Trust Advisors first reported a position in Pear Therapeutics, Inc. Warrant in Q4 2021 and held it in 6 quarters.
Washington Trust Advisors's Pear Therapeutics, Inc. Warrant position peaked at $1K in Q1 2022.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Washington Trust Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.